Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Let’s get the Adderalls and NeedleMovers paid for.
Get rid of their minimal debt then buyback.
It’s going to be way higher than where we are..
It also sends a message of confidence in the company
That could happen after Vyvance launch in a year
Elite should follow Apples lead and do a buy back Their stock shot up 7 percent
Shortages:
FDA shortage link
for Adderall:
https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet&st=c&tab=tabs-1
FDA shortage link for Vyvance
https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Lisdexamfetamine%20Dimesylate%20Capsule&st=c
FDA shortage link for Concerta
https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Methylphenidate%20Hydrochloride%20Tablet,%20Extended%20Release&st=c
FDA shortage link for Naltrexone
https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Naltrexone%20Hydrochloride%20Tablet&st=c
FDA shortage link for Methotrexate
https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Methotrexate%20Sodium%20Tablet&st=c
Catalyst check off:
X 1. Cash Flow Positive Status - 5 years
X 2. Purchase building housing their cGMP registered facility for research, development, manufacturing and packaging of pharmaceutical products.
X 3. Adderall IR $335 Million Approved and Launched
X 4. Adderall XR $1.56 Billion Approved and Launched
X 5. Double digit quarterly revenues in millions
X 6. In house marketing and distribution: Kirko Kirkov, Doug Plassche and their teams
X 7. Prasco/Burel Adderall agreement starting January 1st 2024
X 8. First shipment Adderall XR to PRASCO Dec 2023
X 9. DEA increases manufacturing quotas for Adderall & Vyvance
X 10. Generic Vyvanse - $5.1 BILLION - FDA submission Dec 2023
X 11. FDA Acceptance of Generic OxyContin Sept 2023
__12. Dopamine Agonist (probably Requip XL or Mirapex ER). $12 Million
X 13. Vigabatrin Approval $233 Million
X 14. Pyros Settle Vigabatrin -VigPoder trade mark challenge then LAUNCH
__15. Generic Methotrexate Approval- Antimetabolite $42 Million
__16. $50 million in yearly revenues
X 17. Lease additional manufacturing space and storage vault for new Needle Mover ANDAs - Jan 2024
X 18. PE ratio under 7.0
__19. Generate revenues over $20 million/quarter
__20. Generic OxyContin Approval - FIRST TO FILE Aug 17, 2023 $720 Million
__21. Prevail over Purdue in Generic OxyContin infringement suit - 6 month stay
__22. European distribution - Dexcel partnership approval by Israeli Health
__23. Full ownership of Adderall IR $ 335 Million
__24. Full ownership of Adderall XR $ 1.56 Billion
__25. Generic Concerta- $1.2 BILLION FDA submission
__26. $100 million in yearly revenue
__27. Generic Vyvanse Approval and Launch
__28. $200 million in yearly revenue
__29. Deep pocket partner for SequestOx
__30. Patented Unique ADF (w/o naltrexone)-- NDA
__31. Mikah ANDA (s)
__32. Undisclosed ANDAs/NDAs
__33. DollarLand PPS
__34. Big Pharma bid
__35. Uplist to the NASDAQ Exchange
__36. ELTP Elite Pharmaceutical Buyout - less than 2 1/2 years from Feb 2024
__37. Vegas Baby !!!!!!!
Why not try that when it was 2-3 cents instead, and not 6x higher or more?
That remains the problem with this stupid theory - it makes no logical sense in $$ terms. Lol.
Well, that's not very nice but you really do not think there is a chance that Mikah will try and buy Elite ???????????
IB_🤴🏻
5-10% of $10 billion combined IMS markets
And yours just continues to be added to the ongoing childish posts…
Oh we are well over the classic "Billion" Share mark now ....................
What do you think Mikah will offer ??????????????
IB_🤴🏻
When a person is not truthful, "Hi Longs, (I have muted all the goatlanders)", nothing they post has any truthful value !!!!!!!!!!!!
You have no idea what he will do, you worship him by faith,
IB_🤴🏻
What is going to make this company worth 3.5 to 5 billion ?
He is just saying anything he can to annoy people. He doesn't even know why he has to work this board anymore. There is nothing to say based on the math and he probably knows that too.
Mikah will NEVER buy Elite - the question shows how little you understand of what is going on with this company, OR you are just playing Dumb to make 10 cents for a reply.
Mikah IS Nasrat Hakim - Nasrat Hakim will not take money from his right pocket to put it in his left pocket.
Mikah will be bought by Pfizer or Merck or another big pharma. and the price will START at $3.5 and may go up to $5.
What PPS do you think Mikah will offer for Elite ????????????
IB_🤴🏻
Good luck with that, sincely.
.52 is light years from .13 (and falling).
The CEO/owner of Mikah will never allow a PPS of .52 as long as he controlls both ends, share holders are powerless.
He's the Shepard and the lottery club members are his sheep....sad but true.
Last post today, thanks
Have a tranquil weekend
You said, "in exactly 1 year I plan to retire...4/30/2025
Better be above 30 cents by then smile" !!!!!!!!!!!!!!!!!!!!!!!
So now $0.31 is not enough ............
IB_🤴🏻
at $.52 I would retire on the spot - and keep at least half of my Eltp investment (to secure my retirement).
Schwab Users - soon T+1
https://www.schwab.com/learn/story/7-things-to-know-about-t1-settlement
Much higher volatility
I never said you were a NasRat worshipper .....................
You are The Elite Message Board, "Contrarian" !!!!!!!!!!!!!!!!!
Now reject that and prove me correct,
IB_🤴🏻
"Typically, the average P/E ratio is around 20 to 25. Anything below that would be considered a good price-to-earnings ratio, whereas anything above that would be a worse P/E ratio."
ELTP has a PE of 6.48. If ELTP had an average PE in line with the market the stock price would be around .40 to .52 per share. IMO ELTP is way undervalued.
Hyper sorry in advance for all the Trolls and Bullies on MBs
I’m not a worshipper, I just think it’s incredibly childish. It’s akin to someone claiming you are assigned to be here.
The "Worshippers" get very upset when Elite's Chairman and CEO/ Mikah's owner is referred to as "Rat" !!!!!!!!!!
LoL LoL,
IB_🤴🏻
What's crazy is you have no idea why you are required to post every day.
Will the " Rat" allow this to close above 13 pennies per share today ??
Is the reality of Mikah buying ELTP for pennies per share starting to unfold ?? I think it is.
The maneuvering he has done certainly points to this.
How many dreams will this guy crush, what a shame.....penny stocks, crazy
Note * do bots only ask the same thing;
" why are you here"
Not sure about the news alone. Possibly, but I think increased utilization, revenues and profitability will be the big drivers of share price increase after some bigger generic approvals.
Revenues will increase dramatically after news of new packaging, warehouse facility is up and running and adding to gross sales
Hi Longs, (I have muted all the goatlanders) let's start early discussing the next quarter numbers - this is not yet the posting of your estimates - but more the potential catalysts that will impact the numbers that you will post two weeks before the teleconference
I say -
1. Prasco may surprise us.
2. Adderall drought in pharmacies may play in our favor
3. Kirko Kirkov may have cooked something nice for us
4. feel free to add ...
Cheers
They know why they are here ..... To distract and cause a disturbance as best they can !!!!!!!!!!
They know who sent them here as well, as do you & I know,
We have one hope,
SEC
IB_🤴🏻
What if the " someone" in your conspiracy novel
Is the " Rat" keeping the price down for the Mikah
acquisition of ELTP for a few pennies per share.
How grand would that be for the zealots that kiss
his picture every morning....omg that would be hilarious!!....it is possible, LOFL
and the short position you rant about incessantly,
.21 to .12 is over 60% they have fled already with
their proceeds.....now what ??
I still say ignore option is your best option.
Thanks, enjoy the day
She/Him is the Board 🤡 !!!!!!!!!!!!
Quote: "@NASDAQ2020
I am a legitimate owner of this company stock. I come her looking for tidbits of information regarding the company business activities.
You joined IH 08/29/2012.
You show 25,793 total posts under ELTP
You average 6.08 posts EVERY DAY for the last 11.6 YEARS
I don't know what your plan in or why you are really here with constant boasting about buying more on a weekly basis but the funds didn't arrive or somethign else happened. We have no way to either confirm or deny what you say. The constant bombardment of boasting that appears to be unachievable by any ordinary penny stock follower makes me wonder.
I am a believer in ELTP but I keep my anticipation to myself. I have no business boasting about the future that may or may not happen. A little cheerleading is always nice but you have a serious problem unless you are being paid for your efforts. I cannot say that any of your posts have resulted in any benefit to any of the readers in a positive manner.
Hubris
That probably goes for the other members bragging about the trips to various exotic or expensive places when they know they won't be doing that regardless of what happens.
I am tempted to ignore, not sure yet." End Quote
IB_🤴🏻
HyperSeeker96, what is your opinion on Elite going forward ??????????????
Don't just be a Troll,
IB_🤴🏻
Hi JimmyJoe, I’m going to put a bet on Tarifa to win the Oaks. That’s a low confidence bet. I have a lot more confidence (and money at stake) with Elite. 🍀
Those are exactly the two reasons.
I sold some in the $0.19's that I had bought in the $0.04's & $0.05's but I didn't sell any that I bought when Jerry was CEO ......
IB_🤴🏻
He never bought any.
So you sold your shares?
See, I think whoever is requiring you to be here has a vested interest in the company. Since you don't know why you have to be here, that makes the story more interesting. Years of your life on this job which is sad in and of itself.
Now the company has extremely strong financials, minimal debt, profitable with an absurdly low PE. It is a prime candidate to be bought out. Biggest products are all ahead and the revenues and earnings are already substantial compared to market cap.
So the only reasons you would be here are because there is a large short position that needs to be covered or someone is trying to prep for acquiring the company and needs the stock price cheap.
What's your best guess as to why you are required to be here?
Will a Monster show its head ?
Secret MIKAH Program
signed back on December 3, 2018:
NOTE 20. RELATED PARTY AGREEMENTS WITH MIKAH PHARMA LLC
-- On December 3, 2018, the Company executed a development agreement with Mikah, pursuant to which Mikah and the Company will collaborate to develop and commercialize generic products including formulation development, analytical method development, bioequivalence studies and manufacture of development batches of generic products.
-- The Company received a total of $480,000 from Mikah as an advance payment for the purchase of pharmaceutical materials relating to future product development conducted pursuant to this agreement. This amount was recorded as a deposit and contained within the customer deposits financial statement line item on the consolidated balance sheet.
-- As of the date of this report, the Company has purchased raw materials with an aggregate cost of $542,214 pursuant to this agreement. As of March 31, 2020, the balance due from Mikah was $62,214 and was included in the financial statement line of prepaid expenses and other current assets on the accompanying consolidated balance sheet.
Lockin and Loadin for the next CC
HammerTime Near !
It’s about to Get Real. !!!!!
X 1. Cash Flow Positive Status - 5 years
X 2. Purchase building housing their cGMP registered facility for research, development, manufacturing and packaging of pharmaceutical products.
X 3. Adderall IR $335 Million Approved and Launched
X 4. Adderall XR $1.56 Billion Approved and Launched
X 5. Double digit quarterly revenues in millions
X 6. In house marketing and distribution: Kirko Kirkov, Doug Plassche and their teams
X 7. Prasco/Burel Adderall agreement starting January 1st 2024
X 8. First shipment Adderall XR to PRASCO Dec 2023
X 9. DEA increases manufacturing quotas for Adderall & Vyvance
X 10. Generic Vyvanse - $5.1 BILLION - FDA submission Dec 2023
X 11. FDA Acceptance of Generic OxyContin Sept 2023
__12. Dopamine Agonist (probably Requip XL or Mirapex ER). $12 Million
X 13. Vigabatrin Approval $233 Million
_
X 14. Pyros Settle Vigabatrin -VigPoder trade mark challenge then Launch
__15. Generic Methotrexate Approval- Antimetabolite $42 Million
__16. $50 million in yearly revenues
X 17. Lease additional manufacturing space and storage vault for new Needle Mover ANDAs - Jan 2024
X 18. PE ratio below 8
__19. Generate revenues over $20 million/quarter
__20. Generic OxyContin Approval - FIRST TO FILE Aug 17, 2023 $720 Million
__21. Prevail over Purdue in Generic OxyContin infringement suit - 6 month stay
__22. Legislation to make manufacturing generic drugs more profitable
__23. European distribution - Dexcel partnership approval by Israeli Health
__24. Full ownership of Adderall IR $ 335 Million
__25. Full ownership of Adderall XR $ 1.56 Billion
__26. Generic Concerta- $1.2 BILLION FDA submission
__27. $100 million in yearly revenue
__28. Generic Vyvanse Approval and Launch
__29. $200 million in yearly revenue
__30. Deep pocket partner for SequestOx
__31. Patented Unique ADF (w/o naltrexone)-- NDA
__32. Mikah ANDA (s)
__33. Undisclosed ANDAs/NDAs
__34. DollarLand PPS
__35. Uplist to the NASDAQ Exchange
__36. ELTP Elite Pharmaceutical Buyout - less than 2 1/2 years from Feb 2024
__37. Vegas Baby !!!!!!!
Maybe the ignore option might be a good choice for you. I apologize if my questions cause you strife. If you are not concerned about ELTPi why reply ??
And the political MB thing , not sure where that
comes from, at all.
Last post today, have a stress free evening.
As always I'm here for you.
I would rather talk about the fantasy that you have been calling for for over 10 years now ....
You know, "Dollar Land" ........ You thought it would come in 2014, it didn't ....you thought it would come in 2015, it didn't .... you were sure it would come in 2016 with SequestOx "The Game Changer", it didn't ..... Every year you thought it would come, it hasn't .....
Do you ever get tired of dreaming about a fantasy ???????????????
IB_🤴🏻
Tell us about your goats
Three of ya working hard today. Does trolling political message boards pay better or the same? Worried you might be replaced by bots? That keeps your pay down I am guessing?
Elite has a 🤡 at the company & a 🤡 here on the board ..............
Care to guess who each one might be ???????????
LoL LoL
IB_🤴🏻
Followers
|
962
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
399708
|
Created
|
03/24/09
|
Type
|
Free
|
Moderators jimr1717 mrwrn2010 NASDAQ2020 IB_ namtae Dr JoeBarducci |
Elite needs a Board of Directors that represents all shareholders !!!
Senior Moderator: IB_
Posted: 6/5/23
________________________________________________________________________________________________________________
Elite Pharmaceuticals, Inc. |
Website | Location | Employees | Facility | CEO |
www.elitepharma.com | Northvale, New Jersey | 53 | 55,000 sq ft | Nasrat Hakim |
Products & Pipeline | ||||
Drug | Market Size | Status | Competitors | Marketed By |
Adderall IR | 389.8 M | On Market | 15 | Elite |
Adderall XR | 1.56 B | On Market | 10 | Elite & Prasco |
Dantrolene | 6.3 M | On Market | 2 | Elite |
Isradipine | 5.5 M | On Market | 1 | Elite |
Loxapine | 5 M | On Market | 2 | Elite |
Phendimetrazine | 4.5 M | On Market | 4 | Elite |
Trimipramine | 2 M | On Market | 1 | Elite |
Naltrexone | 16 M | On Market | 5 | Precision Dose |
Phentermine Capsules | 7.5 M | On Market | 6 | Precision Dose |
Phentermine Tablets | 40 M | On Market | 8 | Precision Dose |
Vigabatrin | 233.7 M | On Market | 13 | Pyros |
Doxycycline | 85 M | Approved (Discontinued) | 9 | ---------- |
Tylenol with Codeine | 45 M | Approved (On Hold - Opioid) | 5 | ---------- |
Dopamine Agonist | 12 M | Filed with FDA - 22 Dec 2022 | ---------- | ---------- |
Antimetabolite | 42 M | Filed with FDA - 20 Apr 2023 | ---------- | ---------- |
Generic OxyContin | 720 M | Filed with FDA - 17 Aug 2023 | ---------- | ---------- |
Generic Vyvanse | 5.1 B | Filed with FDA - 21 Dec 2023 | 14 | ---------- |
Generic Concerta | 1.16 B | In Development (Final Stages) | 9 | ---------- |
Financials | ||||
Fiscal Year | Revenue | Change | Net Income | Change |
2019 | 7,568,508 | ---------- | (9,279,321) | ---------- |
2020 | 17,994,639 | +137.76% | (2,240,351) | +75.86% |
2021 | 25,380,749 | +41.05% | 5,088,421 | +327.13% |
2022 | 32,262,117 | +27.11% | 8,898,245 | +74.87% |
2023 | 34,155,114 | +5.87% | 3,561,846 | -59.97% |
2024 Q1 | 8,980,076 | +17.04% | 1,141,809 | +273.28% |
2024 Q2 | 14,157,185 | +64.90% | 14,934,601 | +866.0% |
2024 Q3 | 15,538,800 | +68.00% | 3,500,000 | +80.0% |
FY 2024 Projected | Minimum Projected: 50,000,000 | Minimum YOY Projected Increase of 68.31% | ||
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |